Advertisements

Соталол

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Соталол

What is Sotalol?

Sotalol is a medication used to manage certain types of serious heart rhythm disorders, known as arrhythmias. It belongs to a unique class of drugs that exhibits properties of both beta-blockers and potassium channel blockers. By affecting the electrical signals in the heart, sotalol helps maintain a stable and regular heartbeat.

Mechanism of Action

Sotalol works through a dual mechanism to regulate cardiac rhythm:

  • Beta-Blocking Activity: It inhibits beta-adrenergic receptors, which reduces the impact of stress hormones like adrenaline on the heart. This action helps to slow the heart rate and decrease the force of contraction.
  • Antiarrhythmic Activity: It prolongs the cardiac action potential, specifically by increasing the time it takes for heart cells to electrically recharge. This helps to prevent the rapid or irregular electrical impulses that lead to arrhythmias.

Primary Uses

Sotalol is primarily utilized for the maintenance of normal sinus rhythm in individuals with specific rhythmic conditions, including:

  • Atrial Fibrillation and Flutter: It is used to prevent the recurrence of these irregular rhythms in patients who are currently in a normal rhythm.
  • Ventricular Arrhythmias: It is indicated for the treatment of life-threatening ventricular tachyarrhythmias, which are rapid rhythms originating in the lower chambers of the heart.

Because of its specific effects on the heart's electrical system, sotalol is typically initiated in a monitored clinical setting to ensure the heart responds appropriately to the medication.

Advertisements

What side effects are possible with Соталол?

Possible Side Effects and Safety Information

Sotalol carries a Boxed Warning regarding the risk of life-threatening proarrhythmia, specifically Torsade de Pointes-type ventricular tachycardia, which is associated with dose-related QT interval prolongation. To minimize this risk, regulatory guidance requires initiating or re-initiating the drug in a facility equipped for continuous electrocardiographic (ECG) monitoring and cardiac resuscitation for a minimum of three days or until steady-state drug levels are reached.

Common and Serious Adverse Reactions

Side effects reflect the drug's combined beta-blocking and potassium channel-blocking activity. Common reactions (seen in over 10% of patients in some studies) are typically dose-related and include fatigue, bradycardia (slow heart rate), dizziness, and dyspnea (shortness of breath). Other common reports include headache, nausea, and QTc prolongation.

Serious adverse reactions documented in regulatory sources include severe bradycardia, Second or Third Degree AV block, new onset or worsening heart failure due to negative inotropic effects, and significant hypotension.

Safety Restrictions and Monitoring

Sotalol is contraindicated in patients with a baseline QTc interval greater than 450 msec (for atrial fibrillation/flutter treatment), bronchial asthma or related conditions, severe renal impairment (creatinine clearance less than 40 mL/min), uncontrolled heart failure, and hypokalemia or hypomagnesemia (which must be corrected prior to initiation).

Risk of proarrhythmia is dose-related, increasing at higher doses and in patients with impaired renal function. Therefore, dosing requires a calculation of creatinine clearance and dose adjustment. Furthermore, caution is advised in diabetic patients, as the beta-blocking properties may mask the symptoms of hypoglycemia.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Sotalol overdose requires immediate medical attention and is characterized by severe cardiovascular toxicity and the risk of life-threatening events. This information is derived from authoritative government regulatory documents.

Documented Overdose Manifestations

Officially documented signs of Sotalol toxicity include profound bradycardia (abnormally slow heart rate) and hypotension (low blood pressure), which can lead to cardiogenic shock. A specific and serious risk is the development of Torsade de Pointes (TdP), a life-threatening ventricular arrhythmia. Other manifestations can include bronchospasm and hypoglycemia, with low blood sugar being a common concern in pediatric patients following overdose.

Required Emergency Response

Immediate medical help must be sought right away for any suspected Sotalol overdose. Emergency management, as outlined in regulatory guidance, focuses on supportive care and the reversal of severe symptoms. Measures may include the administration of activated charcoal (for recent ingestion), Atropine or Isoproterenol for bradycardia, and intravenous fluids for hypotension. Specific treatment for Torsade de Pointes typically involves magnesium sulfate. Due to the drug's long half-life, prolonged continuous ECG monitoring in a hospital setting is required, and hemodialysis is an option for severe toxicity.

Population-Specific Notes

Toxicity is heightened in patients with impaired renal function due to reduced drug clearance, increasing the risk of TdP.

Advertisements

Therapeutic Uses of Соталол

What Соталол Treats: Main Uses and Benefits

The primary therapeutic benefit of Соталол is in addressing symptoms related to heightened physiological activity, relevant in contexts involving heightened systemic burden. The medication supports managing the frequency and intensity of episodes associated with heightened physiological stress. Generally, the medication is used across therapeutic domains involving two main categories of conditions.


Key Therapeutic Domains

Соталол is commonly used across conditions presenting with severe, persistent rhythm disturbances. Its primary uses involve the management of documented, sustained Ventricular Tachycardia (VT), a condition marked by increased physiological stress, and the symptomatic support for Atrial Fibrillation (AFIB) and Atrial Flutter (AFL). The drug is commonly applied in cases where symptoms interfere with daily functioning, such as recurring palpitations, dizziness, or lightheadedness.

This supportive benefit contributes to easing the overall symptom load and helps address the return of the irregular heartbeat. This use helps maintain a sense of stability when symptoms are more noticeable, assisting with symptom clusters that may become intense or disruptive.

“This support contributes to improved day-to-day comfort and assists with maintaining functional stability.”

Quick Fact: Supportive Relief for Symptomatic Episodes The medication is relevant for easing symptoms like lightheadedness and palpitations that interfere with daily functioning, supporting patients during difficult episodes by easing distress.

Regulatory References

  1. SOTALOL HYDROCHLORIDE tablet (DailyMed / NIH)
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Соталол?

The eligibility for using Соталол (Sotalol hydrochloride) is strictly defined by official regulatory bodies, focusing on absolute exclusions and specific health requirements for the patient population.


Contraindications (Who Must Not Use)

Official labeling contraindicates the use of Sotalol in patients with several serious conditions, including:

  • Bradycardia (slow heart rate) or certain AV blocks without a functioning pacemaker.
  • Long QT Syndrome or baseline QT intervals greater than 450 msec.
  • Decompensated Heart Failure or Cardiogenic Shock.
  • Bronchial Asthma and other bronchospastic conditions.
  • Severe Renal Impairment (Creatinine Clearance CrCl < 40 mL/min).
  • Uncorrected Hypokalemia (low potassium) or Hypomagnesemia.

Age and Physiological Limitations

Population Regulatory Status
Adults Approved for life-threatening ventricular and highly symptomatic atrial arrhythmias.
Pediatric Patients Approved for specific symptomatic and life-threatening arrhythmias.
Older Adults Use requires caution due to increased likelihood of impaired kidney function, which affects drug clearance.
Pregnancy Generally avoided unless benefits outweigh risks; fetal monitoring is necessary.
Lactation Breastfeeding is not recommended as the drug is excreted in breast milk.

Eligibility is contingent upon correcting electrolyte imbalances and ensuring no formal contraindications exist, as defined by the prescribing information.

Advertisements

What should I know about interactions with other medicines?

Sotalol Interactions with Other Medicines and Products

The regulatory interaction profile for Sotalol is structured around two primary categories of additive effects and specific constraints related to absorption and patient condition.

Interaction Type Examples of Interacting Agents Officially Documented Effect
Additive QTc Prolongation Class III Antiarrhythmics, QTc-Prolonging Drugs (e.g., certain Macrolides, Phenothiazines) Co-administration is a contraindication due to heightened risk of Torsade de Pointes, a severe proarrhythmia.
Additive Cardiodepression Cardiodepressant Calcium Channel Blockers (Verapamil, Diltiazem), Digoxin Increased risk of bradycardia, hypotension, conduction defects, and cardiac failure.

Specific Interaction Rules and Constraints

Administration requires adherence to specific timing rules to manage drug exposure. Aluminum- or magnesium-based antacids are documented to reduce Sotalol absorption; the label therefore mandates that these antacids must be taken at least two hours before or two hours after the Sotalol dose. Official documents also state that Sotalol may mask the symptoms of hypoglycemia in patients using antidiabetics. Furthermore, the severity of the QTc-prolonging interaction is officially documented to be exaggerated by the presence of Hypokalemia or Hypomagnesemia. Renal clearance of the drug is reduced in patients with Renal Impairment, which influences the risk of concentration-dependent QTc prolongation. Discontinuing Clonidine requires prior, gradual withdrawal of Sotalol to mitigate a documented risk of rebound hypertension.

Advertisements

Mechanism of Action

How Sotalol Works

Sotalol exerts its action through two distinct mechanistic domains to influence the heart's electrical properties and sympathetic tone.


️ Modulating Cardiac Action Potential Duration

This domain involves Sotalol's Class III antiarrhythmic activity, where it functions as a non-selective inhibitor of the delayed rectifier potassium currents I Kr (specifically the Kv11.1 channel). This molecular interaction prolongs the repolarization phase of the cardiac action potential, which subsequently lengthens the effective refractory period (ERP) of the atrial and ventricular muscle. The resulting physiological effect is an increase in the non-responsiveness period of the myocardial tissue.


⬇️ Blocking Beta-Adrenergic Receptors

This second domain involves Sotalol's non-selective beta-blockade (Class II activity), where it competitively antagonizes both beta1- and beta2-adrenergic receptors. By blocking the effects of catecholamines (epinephrine and norepinephrine) on these targets, it dampens sympathetic signaling within the heart. The resulting physiological consequences include a decrease in heart rate (negative chronotropy) and a reduction in myocardial contractility (negative inotropy), leading to a decrease in myocardial oxygen consumption.

Advertisements

Dosage and Administration Information

How Sotalol is Used: Official Administration Guidelines

Sotalol is administered via the oral route as a tablet for long-term use and as an intravenous (IV) solution for acute management, typically within a clinical setting. The use of the medication is highly procedural and is governed by standardized dosing and administration rules.


Dosing and Administration Schedule

Parameter Adult Instruction (Normal Renal Function)
Starting Oral Dose 80 mg twice daily (BID)
Maintenance Dose Range 160 mg to 320 mg total daily dose, divided into two doses
Titration Interval Dose increments (e.g., 80 mg/day) must be separated by 2 to 3 days

Sotalol tablets must be taken 1 to 2 hours before meals to ensure consistent absorption, as food can reduce the medicine's bioavailability. If a dose is missed, patients are instructed to take the next scheduled dose at the usual time and must not double the dose.

Population-Specific Adjustments

Since Sotalol is primarily eliminated by the kidneys, dosing frequency must be adjusted based on the patient's renal function, as measured by creatinine clearance (CrCl). For example, in adult patients with a CrCl between 30-59 mL/min, the 12-hour dosing interval is extended to 24 hours (once daily). No dosage adjustment is required for patients with liver impairment.

Advertisements

Recent Clinical Evidence

Соталол: Recent Clinical Evidence

Sotalol is a compound with dual electrophysiological properties, classified as both a non-selective beta-blocker (Vaughan Williams Class II) and a potassium channel blocker (Class III antiarrhythmic). Its primary use, supported by clinical trials, is for managing and preventing certain types of abnormal heart rhythms, known as arrhythmias.

Efficacy in Atrial Arrhythmias

Clinical trials have evaluated the compound's use for maintaining normal sinus rhythm in patients with highly symptomatic Atrial Fibrillation (AF) and Atrial Flutter (AFL). Studies have shown that sotalol is associated with a delay in the time to the first symptomatic, ECG-documented recurrence of AFIB/AFL. Data from these trials suggest that the maintenance of rhythm is dose-dependent, with some studies indicating that a 120 mg twice-daily dose may show greater benefit than 80 mg twice-daily, without the 160 mg dose providing additional benefit in certain populations.

Safety Considerations and Study Outcomes

Research emphasizes the importance of safety monitoring when initiating therapy due to the risk of QT interval prolongation and the potential for a serious ventricular arrhythmia called Torsades de Pointes (TdP). This risk is known to be dose-related.

Area of Research Key Finding from Clinical Studies
Ventricular Arrhythmias Indicated for documented, life-threatening ventricular arrhythmias, though studies have not demonstrated enhanced survival.
Comparative Safety Network meta-analyses have examined comparative safety with other antiarrhythmic drugs, with some data suggesting a lower risk of all-cause death when compared to sotalol.

Sotalol is generally reserved for patients where the benefits of rhythm control are deemed necessary due to the symptomatic nature of the arrhythmia, given the recognized safety profile.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Соталол (FAQ)


Q: Is it common to feel tired when starting Соталол?

Regulatory documents indicate that feeling fatigue and dizziness are listed among the most commonly reported side effects experienced by patients in clinical trials. These effects are generally described as dose-related. Concerns about severe or persistent side effects are generally directed to a healthcare provider.


Q: Does Соталол interact with caffeine?

The official product information does not typically list caffeine specifically. However, certain beta-blockers, including Sotalol, may interact with sympathomimetic agents (a class that includes caffeine) which can affect heart rate and blood pressure. Questions about specific dietary elements, such as caffeine consumption, are typically directed to a healthcare provider.


Q: Is it safe to take Соталол with common pain relievers like Ibuprofen?

Official interaction data suggests that nonsteroidal anti-inflammatory drugs ( NSAIDs) such as ibuprofen may reduce the blood pressure-lowering effect of beta-blockers like Sotalol. If ibuprofen is used frequently or regularly, such situations may require monitoring or a change in management, according to healthcare advice.


Q: Can Соталол be taken with alcohol?

Official information indicates that taking Sotalol with alcohol may lead to additive effects that lower blood pressure further. This combination could increase the risk of side effects like dizziness, headache, or fainting.


Q: What happens if a dose of Соталол is missed?

Regulatory guidance instructs patients to take the next scheduled dose at the usual time and states that the dose should not be doubled to compensate for the missed one. Doubling a dose is specifically warned against as it may cause an unwanted and potentially harmful increase in drug effects.


Q: Is Соталол a treatment that is usually taken long-term?

Yes, official labeling describes Sotalol as a medication that is generally used for the long-term maintenance of a normal heart rhythm in patients with specific conditions.


Q: Are there specific symptoms that require immediate medical attention while on Соталол?

Official patient information describes several serious signs—such as a very slow heart rate ( severe bradycardia), symptoms of worsening heart failure, or signs of proarrhythmia (a new or worse irregular heartbeat, like fainting or new onset of dizziness)—that are typically reported to a healthcare provider immediately.


Q: What are the main findings from research studies on Соталол's use for atrial fibrillation?

Clinical trials reviewed in official documents indicate that Sotalol is effective for the maintenance of a normal sinus rhythm. This means it has been shown to delay the time to the recurrence of Atrial Fibrillation ( AFIB) or Atrial Flutter ( AFL) in highly symptomatic patients.


Q: Can Соталол be taken with antacids?

you should not take Sotalol at the same time as aluminum- or magnesium-based antacids. Regulatory labels mandate that these specific antacids must be taken at least two hours before or two hours after the dose of Sotalol to avoid reducing the absorption of the drug.


Q: Is it common for people to switch from other antiarrhythmics to Соталол?

Yes, official warnings acknowledge that patients may switch from other rhythm-regulating medicines. To reduce the risk of potential drug interactions, the label instructs that certain other antiarrhythmic agents must be withheld for a specific period (often based on the drug's half-life) before starting Sotalol therapy.


Q: How is Соталол different from other beta-blockers like Metoprolol?

Official regulatory documents emphasize that Sotalol is unique because it has mathbftwo distinct mechanisms of action at the recommended dosage. It acts as both a non-selective beta-blocker (Class II activity) and an agent that prolongs the heart's electrical action potential (Class III activity). Other beta-blockers, like Metoprolol, typically only have the beta-blocking Class II activity.


Q: Does Соталол cause weight gain?

According to official compilations of adverse event data, weight changes are sometimes reported as a rare side effect. Most common adverse reactions do not include weight gain.


Q: Are there any major diet restrictions while taking Соталол?

Official documents note one specific constraint regarding food: Sotalol tablets should be taken mathbf1 to mathbf2 hours before meals. This is because food can reduce the amount of medicine absorbed into the body, and this timing helps ensure a consistent effect.


Q: Is it possible for Соталол to make an irregular heartbeat worse?

Yes, regulatory documents carry a Boxed Warning that Sotalol can cause a life-threatening proarrhythmia (making the irregular heartbeat worse). Specifically, it can cause Torsade de Pointes ventricular tachycardia, a severe type of irregular heartbeat, which is associated with the dose and QT interval prolongation.


Q: Is Соталол used only for severe heart conditions?

Official product information indicates that Sotalol is specifically approved for documented, life-threatening ventricular arrhythmias and for highly symptomatic atrial fibrillation/flutter. Its use is generally reserved for patients where the benefits of rhythm control are considered necessary given its safety profile.


Q: Are there any warnings about driving or operating machinery while taking Соталол?

Because the medication can cause side effects such as dizziness, tiredness (fatigue), or low blood pressure, patient information advises caution when driving or operating machinery. The guidance recommends that individuals should wait until they know how the medication affects their stability and alertness before engaging in these activities.


Q: Does Соталол interact with common cold or flu medications?

Some common cold and flu medications may contain ingredients classified as sympathomimetic agents (e.g., decongestants). Official documents note that these agents can increase blood pressure and potentially oppose the action of beta-blockers like Sotalol, leading to adverse cardiovascular effects.


Q: Can Соталол cause problems with sleep?

Although the most common side effect lists do not typically include insomnia, some adverse event compilations mention mood changes and nightmares in rare cases. Persistent sleep problems are typically brought to the attention of a healthcare provider.


Q: Does Соталол affect cholesterol levels?

As part of the beta-blocker class, Sotalol may alter serum lipid profiles in some patients. This effect can potentially include increases in VLDL and LDL cholesterol and triglycerides, and decreases in HDL cholesterol.


Q: Is Соталол considered a common treatment for high blood pressure?

No. Official labeling states that Sotalol's primary indications are for the treatment of specific ventricular and atrial arrhythmias. It is not listed in the official prescribing information for the routine treatment of uncomplicated high blood pressure.


Q: Is it possible for Соталол to cause dizziness or lightheadedness?

Yes. According to the regulatory documents, dizziness is listed among the most common adverse reactions reported during clinical trials, affecting a significant number of patients.


Q: Is there a generic version of Соталол available?

Yes, the active ingredient, mathbfSotalol hydrochloride, is available in generic tablet formulations which meet regulatory standards for efficacy and safety.


Q: What color are Соталол tablets usually?

Sotalol tablets are often described as light-blue, capsule-shaped tablets, according to official product descriptions. The specific color may vary slightly between authorized manufacturers.


Q: Can Соталол cause problems with vision?

Official compilations of adverse events sometimes list vision changes among the rare side effects that have been reported.


Q: Is it expected to feel changes in heart rate while on Соталол?

Yes, Sotalol has a beta-blocking effect which is intended to reduce the resting heart rate. A slower heart rate ( bradycardia) is both an expected physiological effect and a common side effect.


Q: What is the standard regulatory status of Соталол (e.g., FDA-approved)?

Sotalol is an mathbfFDA-approved prescription drug in the United States, and it is approved by other corresponding government health authorities worldwide for the treatment of specific arrhythmias.


Q: Is Соталол commonly prescribed for people with heart failure?

Official warnings note that Sotalol is contraindicated in patients with decompensated heart failure and may mathbfworsen heart failure due to its beta-blocking effects. It is generally not indicated for the primary treatment of heart failure.


Q: Are there any specific laboratory tests that are affected by Соталол?

Official warnings and precautions emphasize the importance of monitoring creatinine clearance (a measure of kidney function) and correcting hypokalemia (low potassium) or hypomagnesemia before starting treatment. These lab values are crucial for safe use and are directly affected by the treatment.


Q: What is the typical elimination half-life of Соталол?

According to the official pharmacokinetics data in the regulatory label, the mean elimination half-life (the time it takes for half of the drug to be removed from the body) of Sotalol is documented to be approximately mathbf12 hours.


Q: Does Соталол affect athletic performance?

Studies have shown that due to its beta-blocking effects, Sotalol slows the heart rate during physical activity. This may result in a reduction of the expected heart rate acceleration achieved during exercise.

Advertisements

How should Соталол be stored and disposed of?

How to Store and Dispose of Sotalol?

The storage and disposal of Sotalol hydrochloride tablets must adhere strictly to regulatory requirements for safety and product stability.

Official Storage Conditions

Sotalol tablets must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F to 77 F). The official label mandates that the container must be tight and light-resistant, kept tightly closed, and stored in a dry place. Excessive heat must be avoided. The medication must always be stored out of the reach of children, often requiring a child-resistant closure upon dispensing.

Disposal Requirements

Unused or expired Sotalol should be disposed of through a dedicated drug take-back program when available. If this is not an option, the drug may be discarded in household trash after being mixed with an undesirable substance, such as dirt or used coffee grounds, and sealed in a container to prevent accidental exposure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Соталол found in:

A-Z Index: